Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Chronic Pancreatitis II: Pathophysiology01:21

Chronic Pancreatitis II: Pathophysiology

Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...
Portal Hypertension01:22

Portal Hypertension

Portal hypertension is an increase in blood pressure within the portal venous system. Normally, this pressure is less than 5 mmHg. It is considered clinically significant when it rises above 10 mmHg. At this threshold, complications from altered blood flow and venous congestion emerge.EtiologyPortal hypertension arises from conditions that impede blood flow through the liver. The most common cause is cirrhosis, in which chronic liver injury leads to fibrotic scarring. This fibrosis narrows or...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Drawing or gesturing? Prior knowledge moderates the impact of embodied pedagogies.

Cognitive research: principles and implications·2026
Same author

When a paraneoplastic lesion meets it's maker-bilateral periocular skin and orbital collision of chronic lymphocytic leukaemia / small lymphocytic lymphoma (CLL/SLL) and necrobiotic xanthogranuloma (NBX) in the same biopsy.

Orbit (Amsterdam, Netherlands)·2026
Same author

Thermal Ablation with or without Liver Transplantation for Hepatocellular Carcinoma in Older Adults with Child-Pugh Class A Cirrhosis.

Journal of vascular and interventional radiology : JVIR·2026
Same author

Selecting Pharmacologic Interventions for MASH.

Digestive diseases and sciences·2026
Same author

Term Infant With Multiple Ulcerative Lesions.

NeoReviews·2026
Same author

Refractory Ascites and the Alfapump.

Gastro hep advances·2026

Related Experiment Video

Updated: Jul 3, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

Pregnancy and cirrhosis.

Jennifer Tan1, Bijal Surti, Sammy Saab

  • 1Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA 90095, USA.

Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
|August 1, 2008
PubMed
Summary

Pregnancy in women with cirrhosis presents unique risks, including higher rates of miscarriage and preterm birth. Careful management of liver disease and medications is crucial for improved maternal and fetal outcomes.

Related Experiment Videos

Last Updated: Jul 3, 2026

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
11:08

The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy

Published on: March 13, 2014

Area of Science:

  • Hepatology
  • Maternal-Fetal Medicine
  • Gastroenterology

Background:

  • Improved cirrhosis treatment is increasing pregnancies in affected patients.
  • While outcomes are improving, pregnant individuals with cirrhosis face distinct complications.

Purpose of the Study:

  • To outline the unique risks and considerations for pregnancy in patients with cirrhosis.
  • To highlight the influence of liver disease etiology and medications on pregnancy outcomes.

Main Methods:

  • Literature review on pregnancy outcomes in cirrhosis patients.
  • Analysis of risks including spontaneous abortion, prematurity, and hemorrhage.
  • Discussion of etiological factors and medication management.

Main Results:

  • Pregnant patients with cirrhosis have increased risks of spontaneous abortion and prematurity.
  • Life-threatening complications such as variceal hemorrhage and hepatic decompensation are significant concerns.
  • Underlying liver disease etiology (e.g., viral, autoimmune hepatitis) and medication regimens impact pregnancy course.

Conclusions:

  • Pregnancy in cirrhosis requires specialized care due to heightened maternal and fetal risks.
  • Tailored medication management and consideration of liver disease etiology are essential for optimizing outcomes.
  • Anticipating and managing complications like hemorrhage and decompensation is critical for patient and infant well-being.